The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Resiliency in the operating room is imperative in today’s health care climate. A well-functioning OR has the potential to increase the number of…
Podcasts
As UDI capture and exchange becomes more prevalent across the healthcare ecosystem and as implantable device information is linked to patient outco
Podcasts
Cybersecurity vulnerabilities and intrusions pose risks for every hospital and its reputation.
Webcast
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
On-Demand Educational Webinars
New risk sharing models align the economics of an agreement to product or service performance and outcomes. In this webinar, we discuss this…